Cargando…

Selenium substitution in patients with severe systemic inflammatory response syndrome (SIRS)

Detalles Bibliográficos
Autores principales:	Angstwurm, MWA, Schottdorf, J, Schopohl, J, Gärtner, R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 1998
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3301256/ http://dx.doi.org/10.1186/cc144

Ejemplares similares

Hormones and not gender influences outcome in severe infection
por: Angstwurm, M, et al.
Publicado: (2001)

Steroid hormone synthesis is impaired in patients with severe sepsis
por: Angstwurm, M, et al.
Publicado: (2003)

Systemic inflammatory response syndrome (SIRS) without systemic inflammation
por: Takala, A, et al.
Publicado: (1998)

Bacteremia and systemic inflammatory response syndrome (SIRS) in confirmed post-partum endometritis
por: Myrianthefs, P, et al.
Publicado: (2000)

Evaluation of blood transfusion effects on mixed venous oxygen saturation and lactate levels in patients with systemic inflammatory response syndrome (SIRS)/sepsis
por: Mazza, BF, et al.
Publicado: (2003)

Autoantibodies against oxidated low density lipoproteins (oLAb) and procalcitonin (PCT) as prognostic markers for patients suffering from sepsis and systemic inflammatory response syndrome (SIRS)
por: Reiger, J, et al.
Publicado: (1998)

APACHE-ll-score-based identification of an escalating systemic inflammatory response syndrome (SIRS) early after cardiac surgery with the assistance of the cardiopulmonary bypass (CPB)
por: Müller-Werdan, U, et al.
Publicado: (1997)

The cardiopulmonary bypass supported high-risk PTCA (CPB-PTCA): a useful model for the study of CPB-dependent systemic inflammatory response syndrome (SIRS)?
por: Prondzinsky, R, et al.
Publicado: (1997)

Procalcitonin is a good marker for the diagnosis of infection and the severity of illness in patients with SIRS
por: Endo, S, et al.
Publicado: (1999)

Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis and septic shock
por: Brunkhorst, FM, et al.
Publicado: (1999)

2151. Accuracy of Physician Adjudication of Infection in Patients with Systemic Inflammatory Response Syndrome (SIRS)
por: Walker, Morgan, et al.
Publicado: (2018)

A new diagnostic and severity marker in patients with SIRS, sepsis, severe sepsis and septic shock; procalcitonin
por: Çelebi, S, et al.
Publicado: (2000)

SIRS in ICU: a different approach in sepsis assessment: clinical predictivity, severity scores, costs
por: Oggioni, R, et al.
Publicado: (1997)

Procalcitonin (PCT) for monitoring ICU patients with severe polytrauma and early SIRS: results of a prospective study
por: Stiletto, RJ, et al.
Publicado: (1998)

Selenium and risk of bladder cancer
por: Złowocka-Perłowska, E, et al.
Publicado: (2012)

Cytokine removal from plasma of patients with SIRS by the Biologic-DTPF(™)
por: Levy, H, et al.
Publicado: (1998)

Circulating complement proteins for differentiation of SIRS and sepsis
por: Sungurtekin, H, et al.
Publicado: (2003)

Selenium and cancer prevention
por: Rayman, Margaret
Publicado: (2012)

Effects of systemic inflammatory response syndrome on intraabdominal pressure and lung compliance
por: Tur, Y, et al.
Publicado: (2002)

Treatment of postoperative lung injury in patients with SIRS by methylprednisolone
por: Sumida, M, et al.
Publicado: (1998)

Selenium and gastrointestinal cancers risk
por: Lener, Marcin, et al.
Publicado: (2012)

Selenium as diagnostic marker of cancers
por: Jaworska-Bieniek, Katarzyna, et al.
Publicado: (2015)

High-dose aprotinin reduces systemic inflammatory response syndrome during CABG
por: Tassani, P, et al.
Publicado: (1999)

Neutrophils and the Systemic Inflammatory Response Syndrome (SIRS)
por: Sikora, Janusz P., et al.
Publicado: (2023)

Selenium and the risk of cancer in BRCA1 carriers
por: Lubinski, J, et al.
Publicado: (2011)

The changes in platelet function in SIRS, sepsis and MODS -- a tight connection to the changes in the immune and hemostatic system
por: Leonhardt, U, et al.
Publicado: (2000)

Bioelectrical impedance analysis as a predictor for survival in patients with systemic inflammatory response syndrome
por: Swaraj, S, et al.
Publicado: (2003)

Selenium (Se) and breast cancer risk
por: Jaworska - Bieniek, Katarzyna, et al.
Publicado: (2012)

The effect of Selenium on thyroid physiology and pathology
por: Skowrońska-Jóźwiak, Elżbieta
Publicado: (2015)

Selenium and the risk of cancer of the lung and larynx. A case-control study from a region with low selenium
por: Jaworska, Katrzyna, et al.
Publicado: (2012)

Selenium and genotypes as marker of risk in BRCA1 mutation carriers
por: Jaworska, K, et al.
Publicado: (2012)

Is gastric malperfusion and endotoxemia one motor of the systemic inflammatory response syndrome following cardiac surgery?
por: Groetzner, JP, et al.
Publicado: (1999)

Association of soluble and cell-linked selectins, multiple organ dysfunction and systemic inflammatory response syndrome
por: Höfler, S, et al.
Publicado: (1997)

Systemic inflammatory response during ventilator-associated pneumonia
por: Lepousé, C, et al.
Publicado: (2001)

Selenium and the risk of cancers of the colon, pancreas and stomach
por: Lener, Marcin, et al.
Publicado: (2012)

Effect of antithrombin III on inflammatory immune response in patients with severe sepsis
por: Inthorn, D, et al.
Publicado: (1998)

Differential diagnosis of Th1/Th2-response by T-cell and monocyte function between sepsis and non-infectious SIRS via flowcytometry
por: Imamura, Y, et al.
Publicado: (2001)

Selenium and cancer risk in CHEK2 mutation carriers
por: Gupta, Satish, et al.
Publicado: (2012)

Selenium (Se) and the risk of breast, ovarian and prostate cancers
por: Jaworska, Katarzyna, et al.
Publicado: (2012)

Systemic inflammatory response syndrome (SIRS) induced by carbon tetrachloride in rats
por: Gergely, J., et al.
Publicado: (1997)

Cannot write session to /tmp/vufind_sessions/sess_4jef73h5ctfds6g2oiifu6nt7g